IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMAIONI, Emidio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.228
EU - Europa 3.304
AS - Asia 2.744
SA - Sud America 485
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 10.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.155
SG - Singapore 1.309
UA - Ucraina 669
IE - Irlanda 613
IT - Italia 535
HK - Hong Kong 428
BR - Brasile 416
CN - Cina 408
RU - Federazione Russa 358
DE - Germania 268
SE - Svezia 264
VN - Vietnam 236
FI - Finlandia 197
GB - Regno Unito 111
KR - Corea 97
TR - Turchia 89
PL - Polonia 56
FR - Francia 54
IN - India 36
CA - Canada 32
NL - Olanda 27
MX - Messico 26
CH - Svizzera 25
BE - Belgio 23
AR - Argentina 21
AT - Austria 21
JP - Giappone 21
CZ - Repubblica Ceca 20
BD - Bangladesh 19
ES - Italia 16
UZ - Uzbekistan 14
ZA - Sudafrica 14
GR - Grecia 12
ID - Indonesia 12
RO - Romania 12
CO - Colombia 11
EC - Ecuador 11
CL - Cile 9
EG - Egitto 9
LT - Lituania 9
PK - Pakistan 9
IL - Israele 8
LB - Libano 8
IQ - Iraq 7
MA - Marocco 7
EU - Europa 6
PY - Paraguay 6
JO - Giordania 5
PH - Filippine 5
SV - El Salvador 5
AZ - Azerbaigian 4
OM - Oman 4
VE - Venezuela 4
AM - Armenia 3
BG - Bulgaria 3
DZ - Algeria 3
JM - Giamaica 3
PE - Perù 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
IR - Iran 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
SA - Arabia Saudita 2
TH - Thailandia 2
TM - Turkmenistan 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
NE - Niger 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
Totale 10.814
Salva come PNG Salva come JPEG
Città #
Singapore 816
Dublin 608
Chandler 555
Hong Kong 425
Jacksonville 409
San Mateo 336
Boardman 214
Ashburn 204
Santa Clara 192
Perugia 182
Altamura 165
Medford 156
Princeton 154
Dong Ket 119
Moscow 113
Lawrence 105
Wilmington 103
Ann Arbor 97
Seoul 97
Beijing 89
Munich 87
Andover 86
Los Angeles 77
Izmir 74
New York 61
Redmond 58
Des Moines 55
Saint Petersburg 49
São Paulo 40
Ho Chi Minh City 39
The Dalles 36
Piscataway 33
Helsinki 31
Turku 27
Hanoi 24
Norwalk 23
Dallas 22
Brussels 21
San Paolo di Civitate 21
Brooklyn 20
Chicago 20
London 20
Denver 18
Tokyo 18
Woodbridge 18
Rome 16
San Francisco 16
Warsaw 16
Boston 15
Phoenix 15
Montreal 14
Orem 14
Poplar 14
Shanghai 14
Nuremberg 13
Rio de Janeiro 13
Johannesburg 12
Stockholm 12
Bucharest 11
Den Haag 11
Redwood City 11
Atlanta 10
Auburn Hills 10
Belo Horizonte 10
Charlotte 10
Chennai 10
Houston 10
Mexico City 10
Ankara 9
Milan 9
Zhengzhou 9
Falls Church 8
Olomouc 8
Tashkent 8
Tianjin 8
Brno 7
Cairo 7
Haiphong 7
Hefei 7
Krakow 7
San Diego 7
Toronto 7
Annapolis 6
Bogotá 6
Florence 6
Guangzhou 6
Lausanne 6
Mcallen 6
Ness Ziona 6
Renton 6
Seattle 6
Secaucus 6
Simi Valley 6
Amman 5
Amsterdam 5
Brasília 5
Campinas 5
Curitiba 5
Detroit 5
Frankfurt Am Main 5
Totale 6.613
Salva come PNG Salva come JPEG
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 147
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 144
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 119
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 113
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 111
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 107
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 106
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 105
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 104
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 103
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 103
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 103
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 102
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 101
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 100
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 99
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 97
Metabotropic glutamate receptors: structure and new subtype-selective ligands 96
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 96
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 96
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 95
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 95
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 94
Targeting the FXR nuclear receptor through a virtual screening approach 94
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 94
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 92
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 92
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 91
Estimating the hydrophobicity extent of molecular fragments using reversed‐phase liquid chromatography 89
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 89
PARP inhibitors: polypharmacology versus selective inhibition 89
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 89
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 88
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 88
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 87
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 87
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 86
Preparation and use of nucleotide bisphosphate as P2Y antagonists 86
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 86
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 85
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases 85
Dexpramipexole improves bioenergetics and outcome in experimental stroke 85
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 82
Circular Hazelnut Protection by Lignocellulosic Waste Valorization for Nanopesticides Development 82
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 81
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 81
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 81
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 80
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 80
Bile acids: property-activity relationship and molecular modelling studies 80
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 79
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 78
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 78
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 77
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 77
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 77
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 77
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 77
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 76
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 75
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 75
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 75
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 75
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 75
Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent 74
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 74
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 73
A Green Nanostructured Pesticide to Control Tomato Bacterial Speck Disease 70
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C 70
Fast chromatographic determination of the bile salt critical micellar concentration 69
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 69
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 68
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 68
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 68
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 67
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 67
Insights in the PARP1 poisoning effect 67
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 66
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 66
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 65
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 65
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 64
Boosting Immunity and Management against Wheat Fusarium Diseases by a Sustainable, Circular Nanostructured Delivery Platform 63
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 63
Quantitative analysis of cucurbitane-type triterpenes in Ibervillea sonorae extracts: Relationship study with their antiproliferative activity 63
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 63
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 62
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 62
Stereoselective Synthesis and Preliminary Evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): Identification of (+)-3-MATIDA as a Novel mGluR1 Competitive Antagonist 61
Use of RP-HPLC on a Dynamically Coated Artificial Membrane to Predict Intestinal Absorption of Bile Acids 61
Heterocycles as companions on route to drug discovery 60
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 60
Towards Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 60
Heterocycles as Companions on Route to Drug Discovery 60
Synthesis and Receptor Affinity of Polysubstituted Adenosines 60
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 60
Effects of Molecular Dynamics and Replica Exchange Molecular Dynamics in Sampling the Conformational Space of PARP-1 60
Novel Isoquinoline-Derived Inhibitors of Poly(ADP-Ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia 60
Compendio teorico-pratico di analisi farmaceutica. Riconoscimento delle sostanze solide iscritte nelle vigenti farmacopee 60
Combined strategies toward the design and synthesis, of novel inhibitors of indoleamine-2,3-dioxygenase (IDO) 59
Totale 8.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021684 0 0 0 0 0 69 121 29 169 32 119 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024851 47 104 44 12 7 15 182 29 88 28 132 163
2024/20252.064 22 202 73 62 252 105 122 93 442 154 319 218
2025/20262.400 339 357 251 529 591 333 0 0 0 0 0 0
Totale 11.230